Delivery Order SPE2DB22D9207-SPE2DB24FH4VX
Award Date 1/5/24
Potential Completion Date 1/29/24
Potential Value $65K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product KEYTRUDA 100 MG/4 ML VIAL 4ML. The order has a completion date of December 20, 2022 and a potential value of $111,353.40. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal government,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide KEYTRUDA 100 MG/4 ML VIAL 4ML. The order has a potential value of $80,285.70 and a completion date of February 8, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that supports the Department of Defense with a wide range of brand and generic prescription and over-the-counter drug supplies. This delivery order is part...
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide KEYTRUDA 100 MG/4 ML VIAL 4ML. The award, valued at $116,257.80, has a completion date of February 10, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that supplies a wide range of prescription and over-the-counter drug items to the federal government, particularly the Department of Defense. This delivery order is issued against...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Keytruda 100 mg/4 ml vial (4 ml). This delivery order, valued at $149,584.40, is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA Troop Support Medical to supply a variety of pharmaceutical and medical items to military treatment facilities worldwide. The contract does not have a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide KEYTRUDA 100 MG/4 ML VIAL 4ML. The order has a potential value of $80,285.70 and a completion date of February 8, 2024. DMS Pharmaceutical Group Inc. holds an indefinite delivery contract with DLA to supply a variety of pharmaceutical and medical products to support military treatment facilities globally. This specific order is delivered under...
- The Defense Logistics Agency has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide KEYTRUDA 100 MG/4 ML VIAL 4ML. The contract has a potential value of $8,021.84 and a completion date of January 31, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that supplies a variety of brand and generic prescription and over-the-counter drug supplies to the federal government, primarily the Department of Defense....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product KEYTRUDA 100 MG/4 ML VIAL 4ML. The contract has a completion date of January 30, 2024 and a potential value of $24,065.52. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles with DLA to supply a variety of prescription...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide KEYTRUDA 100 MG/4 ML VIAL 4ML with a potential value of $116,257.80. The order has a completion date of June 15, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and Indefinite Delivery Vehicles (IDVs) to supply pharmaceuticals and medical products to the Department...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide KEYTRUDA 100 MG/4 ML VIAL 4ML. The delivery order has a potential value of $48,131.04 and a completion date of January 30, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds numerous federal contracts and indefinite delivery vehicles to supply a wide range of pharmaceuticals and medical...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,559,396,275 units of the pharmaceutical item KEYTRUDA 100 MG/4 ML VIAL 4ML. The $117,514.94 delivery order has a completion date of January 5, 2023. DMS Pharmaceutical Group is an experienced federal contractor that holds various contracts and indefinite delivery vehicles with the Defense Logistics Agency to supply a wide...
- SPE2DB22D9207Indefinite Delivery Contract
- SPE2DB22D9207-SPE2DB24FH4VXDelivery Order
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $65,452.74 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product KEYTRUDA 100 MG/4 ML VIAL 4ML. This delivery order is part of a larger indefinite delivery contract that DMS Pharmaceutical Group holds with DLA to supply a variety of pharmaceutical and medical products to military treatment facilities worldwide. The contract does not have a set-aside designation and is set to be completed by January 29, 2024. DMS Pharmaceutical Group is an experienced federal contractor that has been providing pharmaceutical and medical supplies to the Department of Defense for over 20 years.
Generated 4/5/24, 10:40 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $65.5k | 1/5/24 |